Yazılar

SoftBank Shares Drop as Nvidia Stake Sale Reveals Deep AI Funding Demands

SoftBank Group (9984.T) shares plunged as much as 10% on Wednesday, after the company’s $5.8 billion sale of its Nvidia stake raised questions about how it will finance its massive new AI investment spree, including major commitments to OpenAI.

The Japanese conglomerate is preparing to fund a $22.5 billion follow-on investment in OpenAI, alongside a $6.5 billion acquisition of chipmaker Ampere and a $5.4 billion purchase of ABB’s robotics division. Analysts estimate these moves bring SoftBank’s recent spending commitments to over $41 billion.

Despite holding 4.2 trillion yen ($27.9 billion) in cash at the end of September, CreditSights analyst Mary Pollock said the group’s short-term funding needs remain “substantial.” She added that SoftBank will likely need to “be proactive” in sourcing additional liquidity to sustain its AI push.

The selloff also reflects investor concerns that tech valuations are overstretched, even as SoftBank doubles down on its “all-in” strategy for artificial intelligence. Founder and CEO Masayoshi Son, long known for his high-risk investing style, remains confident that AI will define the next era of growth.

“The Nvidia position was large, liquid, and easy to monetize,” said Rolf Bulk, analyst at New Street Research, noting that SoftBank likely sees more upside by reallocating funds toward OpenAI.

SoftBank’s shares, which had quadrupled between April and October, closed the day down 3.46% after paring earlier losses. Nvidia and Arm Holdings, the chip designer SoftBank controls, also slipped around 3% overnight.

To fuel its aggressive investment agenda, SoftBank has raised funds through bond issuances and multi-billion-dollar loans, including an $8.5 billion facility for OpenAI and a $6.5 billion bridging loan for Ampere. CFO Yoshimitsu Goto said the group’s debt ratio of 16.5% is “actually a bit too safe,” signaling room for more leverage.

SoftBank’s Vision Fund CFO Navneet Govil defended the spending, arguing that today’s AI sector is fundamentally different from past speculative bubbles: “AI companies are generating meaningful revenues. The capital expenditure boom is driven by real demand.”

Foxconn Sees AI Boom Driving 2026 Growth, Hints at OpenAI Collaboration

Foxconn, the world’s largest contract electronics manufacturer and key supplier to Apple and Nvidia, projected strong growth from artificial intelligence (AI) demand heading into 2026 — and teased a major announcement with OpenAI next week.

Chairman Young Liu told investors on Wednesday that the AI industry was only in its early stages and would soon become a central driver of global technology growth.
“Judging from what we see now, I am very optimistic about the AI market next year,” Liu said during the company’s quarterly earnings call. “The development of AI is still just beginning.”

Foxconn’s cloud and networking division, which includes AI server manufacturing, has now surpassed its consumer electronics segment — which includes iPhones — for the second consecutive quarter.

The company expects significant year-on-year revenue growth in the fourth quarter, with AI server sales continuing to rise quarter-on-quarter. Third-quarter profit jumped 17% to T$57.67 billion ($1.89 billion), beating analyst expectations.

Liu also hinted at an OpenAI-related announcement to be revealed during Foxconn’s annual Tech Day in Taipei next week, but declined to provide further details. OpenAI has not yet commented on the matter.

Foxconn — formally known as Hon Hai Precision Industry — has benefited from a global data center expansion led by Amazon, Microsoft, and Google, as they ramp up investments in AI infrastructure.

Beyond AI, Foxconn continues to invest in electric vehicles (EVs), despite recent challenges in its EV manufacturing ventures in the U.S.

So far this year, Foxconn’s shares have risen 36%, outperforming Taiwan’s broader market index, which is up 21%.

OpenAI Explores Generative AI Health Tools in Expansion Beyond ChatGPT

OpenAI is reportedly exploring consumer health products, including a generative AI-powered personal health assistant, as part of its efforts to expand beyond its core AI offerings, according to Business Insider, citing people familiar with the matter.

The move marks a major step for the ChatGPT developer as it looks to enter the highly regulated and competitive healthcare sector. OpenAI declined to comment on the report.

The company’s healthcare ambitions come after a series of strategic hires earlier this year. In June, OpenAI appointed Nate Gross, cofounder of the physician networking platform Doximity, as head of healthcare strategy, followed by former Instagram executive Ashley Alexander joining as vice president of health products in August.

Speaking at the HLTH conference in October, Gross revealed that ChatGPT attracts around 800 million weekly active users, with a significant number seeking medical or health-related advice through the platform.

OpenAI’s expansion into health mirrors earlier efforts by Google, Amazon, and Microsoft to give consumers more control over their medical data—attempts that largely fell short. Google shut down its Health Records project in 2011, Amazon ended its Halo fitness tracker business in 2023, and Microsoft’s HealthVault also failed to gain widespread adoption.

If realized, OpenAI’s health assistant could integrate generative AI with personalized wellness and medical insights, potentially transforming how consumers manage their health. However, regulatory and ethical challenges around data privacy and medical accuracy are expected to be key hurdles.